Cramer’s lightning round: Charles River is a buy

Alibaba Group Holding Ltd: “I do not want you to touch that stock.”

Sherwin-Williams Co: “The price-to-earnings multiple is still way too high on that stock. … I think the stock goes lower.”

Charles River Laboratories International Inc: “It finally doesn’t have a high price-to-earnings multiple. I would actually start buying that stock right here, right now.”

Cassava Sciences Inc: “This is the kind of company that could strike gold or not, but you’ve got to understand you could lose everything.”

Revance Therapeutics Inc: “It’s good in this environment. It’s okay to buy.”

Boeing Co: “Right now, you’ve still got to avoid the stock.”

CS Disco Inc: “Don’t need it. Don’t want it.”

Seagen Inc: “I think Merck has to buy it. I would not sell this stock here, I’d be a buyer.”

Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.

Disclaimer